1. Home
  2. ELTX vs ELMD Comparison

ELTX vs ELMD Comparison

Compare ELTX & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$3.60

Market Cap

185.4M

Sector

Health Care

ML Signal

HOLD

Logo Electromed Inc.

ELMD

Electromed Inc.

HOLD

Current Price

$43.54

Market Cap

208.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTX
ELMD
Founded
2011
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.4M
208.1M
IPO Year
2014
2010

Fundamental Metrics

Financial Performance
Metric
ELTX
ELMD
Price
$3.60
$43.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$18.00
$36.00
AVG Volume (30 Days)
4.0M
72.3K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
39.29
46.55
EPS
N/A
0.91
Revenue
$2,301,000.00
$54,716,000.00
Revenue This Year
N/A
$15.59
Revenue Next Year
N/A
$11.51
P/E Ratio
N/A
$50.22
Revenue Growth
N/A
13.83
52 Week Low
$2.66
$17.73
52 Week High
$16.00
$47.40

Technical Indicators

Market Signals
Indicator
ELTX
ELMD
Relative Strength Index (RSI) 37.20 65.54
Support Level $2.66 $23.51
Resistance Level $9.44 N/A
Average True Range (ATR) 0.82 1.84
MACD -0.05 0.33
Stochastic Oscillator 20.93 67.73

Price Performance

Historical Comparison
ELTX
ELMD

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About ELMD Electromed Inc.

Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

Share on Social Networks: